---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-079855"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T12:12:44.997958+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics closes asset sale; Chapter 11 liquidation plan confirmed, equity canceled

## Summary
- On August 8, 2025, closed sale of certain assets to Indaba Starling (affiliate of Indaba Capital) under amended asset purchase agreement.
- On August 13, 2025, Bankruptcy Court confirmed Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation.
- Plan effective date expected on or about August 18, 2025; all common stock and warrants canceled, holders receive no distribution.
- As of confirmation, company had approximately 25,477,516 shares outstanding with no shares reserved for future issuance.

## SEC filing metadata
- accession: 0001104659-25-079855
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 1.03, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/tm2523695d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-079855
- JSON: https://secwatch.observer/filing/0001104659-25-079855.json
- Plain text: https://secwatch.observer/filing/0001104659-25-079855.txt

## Key facts
- Distress & Bankruptcy
  Accelerate Diagnostics, Inc entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2025-05-08).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2025-05-08
  source text: As previously disclosed, on May 8, 2025, Accelerate Diagnostics, Inc., a Delaware corporation (the “ Company ”), and its US subsidiary, Accelerate Diagnostics Texas, LLC (collectively, with the Company, the “ Company Parties ”), filed voluntary petitions for relief (the “ Bankruptcy Petitions ”) under Chapter 11 of the United States Code (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Delaware (such court, the “ Court ” and such cases, the “ Cases ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm
- M&A Transactions
  Accelerate Diagnostics, Inc completed a disposition involving an affiliate of Indaba Capital Management, L.P. (closed 2025-08-08).
  - Action: disposition
  - Counterparty: an affiliate of Indaba Capital Management, L.P.
  - Closing: 2025-08-08
  source text: On August 8, 2025, the Company and Buyer consummated the Sale Transaction.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.